Aurinia Pharm Ord
(AUPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -19,421 | N/A | N/A | N/A |
| Depreciation Amortization | 1,303 | N/A | N/A | N/A |
| Accounts receivable | 9 | N/A | N/A | N/A |
| Other Working Capital | -2,230 | N/A | N/A | N/A |
| Other Operating Activity | 3,431 | 0 | 0 | 0 |
| Operating Cash Flow | $-16,908 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -9,994 | N/A | N/A | N/A |
| PPE Investments | -86 | N/A | N/A | N/A |
| Investing Cash Flow | $-10,080 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 49,490 | N/A | N/A | N/A |
| Other Financing Activity | -1,600 | 0 | 0 | 0 |
| Financing Cash Flow | $47,890 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -17 | N/A | N/A | N/A |
| Beginning Cash Position | 1,821 | N/A | N/A | N/A |
| End Cash Position | 22,706 | N/A | N/A | N/A |
| Net Cash Flow | $20,885 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -16,908 | N/A | N/A | N/A |
| Capital Expenditure | -90 | N/A | N/A | N/A |
| Free Cash Flow | -16,998 | 0 | 0 | 0 |